A Mild Multi-Component Reaction for the Synthesis of 4,5-Disubstituted 1H-1,2,3-Triazoles from Phosphonium Salts, Aldehydes, and Sodium Azide

Abstract

A mild and metal-free multi-component reaction to synthesize 4,5-disubstituted 1H-1,2,3-triazoles from phosphonium salts, aldehydes, and sodium azide is described. The process undergoes an organocatalyzed coupling of formyl group with phosphonium to form a key intermediate, olefinic phosphonium salt, which is followed by the [3+2] cycloaddition of the azide to the activated alkene. A series of representative 4,5-disubstituted 1H-1,2,3-triazoles were prepared.

Key words

phosphonium salt - triazole - organic catalyst - multicomponent reaction - cycloaddition

1,2,3-Triazoles are an important class of heterocyclic compounds, which have been widely used in organic synthesis,[1] medicinal chemistry,[2] and the development of new materials.[3] Therefore, many methods have been developed to synthesize 1,2,3-triazoles till now.[4] Among these developed approaches, most are for N-substituted 1,2,3-triazoles, and only a few are for N-unsubstituted 1,2,3-triazoles, which also have wide applications.[5] Construction of 4,5-disubstituted 1H-1,2,3-triazoles can be achieved via a tandem three-component reaction, involving the coupling of Julia reagent,[5h] nitroalkene,[5e] [j] [k] or cyanocarbonyl compounds[5i] with aldehyde, followed by cycloaddition with sodium azide. In this paper, we report a mild method to synthesize 4,5-disubstituted 1H-1,2,3-triazoles by a multi-component reaction from commercially inexpensive phosphonium salts, aldehydes, and sodium azide.

Phosphonium salts are usually deprotonated with a strong base to form phosphorus ylides, which have been studied intensively ever since the Wittig reaction became popular in the 1950s (Scheme [1])[6a] [b] including new methods for the generation of phosphorus ylides,[6b,c,j] the synthesis of modified nucleosides,[6d] vinyl isocyanides,[6e] and macro­cycles;[6f] by-product separation,[6g] and stereo- and regioselective olefination.[6h] [i] We envisioned that phosphonium salt could also couple with aldehyde to form olefinic phosphonium salt, which is followed by a [3+2] cycloaddition with azide to produce a triazole ring as do acrylonitriles[5a] and α-haloacrylates (Scheme 1).[5g]

Scheme 1 Reactions of phosphonium salts

Olefinic sulfur salt intermediates are formed via the coupling of sulfur salts with aldehydes in the presence of l-proline.[7] Thus, our initial experiment was performed with (ethoxycarbonylmethyl)triphenylphosphonium bromide (1a), benzaldehyde (2a), and NaN₃ catalyzed by l-proline. The mixture was stirred in DMSO solution at room temperature for 24 hours and the expected product, triazole 3a, was obtained in a 75% isolated yield. The Wittig product 4a was collected in an 11% yield (Table [1], entry 1). When the reaction was performed at 80 °C, the yield for the triazole product was reduced to 50%, and the yield of the by-product, olefin, increased to 25% (entry 2). Thus, high temperature does not favor triazole formation. When DMSO was replaced with EtOH, MeOH, or MeCN as the solvent, all the reactions were negative (entries 3–5). In DMF solution, the yield of the main product, triazole, was moderate (51%, entry 6). In a weak polar solvent, tetrahydrofuran or 1,4-dioxane, only the olefin product was produced in a yield of 61% or 52%, respectively, which is the Wittig reaction, and was probably attributable to the insolubility of NaN₃ (entries 7 and 8). Neither triazole 3a nor olefin 4a was observed in the water solution (entry 9). However, in a solution of DMSO/ H₂O (9:1, v/v), triazole 3a and olefin 4a were obtained in isolated yields of 32% and 40%, respectively (entry 10).

Table 1 Optimization of the Reaction Conditions^a

Entry	Solvent	Catalyst (mol%)	Yield of 3a (%)b	Yield of 4a (%)b
1	DMSO	Proline (10)	75	11
2c	DMSO	Proline (10)	50	25
3	MeOH	Proline (10)	trace	trace
4	EtOH	Proline (10)	trace	trace
5	MeCN	Proline (10)	trace	trace
6	DMF	Proline (10)	51	15
7	THF	Proline (10)	trace	61
8	1,4-Dioxane	Proline (10)	trace	52
9	H2O	Proline (10)	trace	trace
10	DMSO/H2O (9:1)	Proline (10)	32	40
11	DMSO	Morpholine (10)	71	16
12	DMSO	Piperidine (10)	68	18
13	DMSO	Glycine (10)	67	15
14	DMSO	Serine (10)	71	13
15	DMSO	K2CO3 (100)	trace	81
16	DMSO	K2CO3 (10)	trace	13
17	DMSO	TsOH (20)	NR	NR
18	DMSO	–	NR	NR

^a Reagents and conditions: 1a (345 mg, 0.8 mmol), PhCHO (2a; 128 mg, 1.2 mmol), NaN₃ (79 mg, 1.2 mmol), catalyst, and solvent (5 mL), r.t., 24 h. NR: No reaction.

^b Isolated yields.

^c The reaction was performed at 80 °C for 24 h.

The catalytic activities of both morpholine and piperidine were also examined and both proved to be effective in selectively producing the triazole product 3a in yields of 71% and 68%, respectively (Table [1], entries 11 and 12). Other amino acids like glycine and serine were also examined and good yields were observed (entries 13 and 14). Notably, the amount of l-proline or amines used in this procedure was only 10 mol% of the phosphonium salt, rather than the stoichiometric amount of a base that is usually involved in the Wittig reaction.[8] Additionally, Wittig product 3a was obtained in 81% and 13% yields and trace triazole product was observed when K₂CO₃ was used in 100 mol% and 10 mol%, respectively (entries 15 and 16), indicating that strong bases promote the formation of the Wittig product.[9] p-Toluenesulfonic acid was unsuitable for the formation of triazole or olefins (entry 17). In the control experiment, no product was formed in the absence of l-proline or amines (entry 18).

With the optimized conditions, the scope of aldehydes in this multistep reaction was screened (Scheme [2]). The results indicated that electron-donating groups (Me, MeO, MeS, or NMe₂) or weakly electron-withdrawing groups (F, Cl, Br, or CF₃₎ on the aromatic aldehydes favored the generation of the corresponding triazoles in yields of 63–81% (compounds 3b–j). However, strong electron-withdrawing groups (CN, NO₂, and CO₂Me) did not favor this tandem reaction (yields: 31–45%, 3l–n). 4,5-Disubstituted 1H-1,2,3-triazole 3k containing a phenol hydroxyl group was formed in a much lower yield (28%). Compared with thiophen-2-yl aldehyde, pyridine-3-yl aldehyde gave rise to a much lower yield (yield: 35% and 63% for compounds 3o and 3p, respectively). Furthermore, butyraldehyde produced the corresponding triazole 3q in a 71% yield, similar to the results for aromatic aldehydes with an electron-donating group (compounds 3a–d).

Scheme 2 Triazoles generated from various aldehydes

Besides the (ethoxycarbonylmethyl)triphenylphosphonium bromide (1a) described above, phosphonium salts prepared by the quaternization of triphenylphosphine with bromomethyl ketone compounds were also examined under mild conditions (Scheme [3]). The results indicated that the electron-withdrawing phenyl ketone produced α-keto 1H-1,2,3-triazoles in lower yields (5c vs 5a and 5b) than the cyclopropyl bromomethyl ketone. Under similar conditions, (cyanomethyl)triphenylphosphonium bromide showed good reactivity in the formation of a few corresponding 1H-1,2,3-triazoles 5d–f. (Benzyl)triphenylphosphonium bromide failed to be transformed to the corresponding triazole product 5g possibly because of the failure in the coupling of benzaldehyde with the phosphonium salt under these mild conditions. However, acylmethyl and cyanomethylphosphonium salts can generate 4,5-disubstituted 1H-1,2,3-triazoles through their sequential coupling with aldehyde and NaN₃ under these mild metal-free conditions.

Scheme 3 Triazoles generated from various phosphonium salts and aldehydes

To clarify the mechanism, LC-MS was used to monitor the reaction of (ethoxycarbonylmethyl)triphenylphosphonium bromide (1a) with 4-methylthiobenzaldehyde, and NaN₃ for triazole 3h. The mass spectrum (positive ESI) showed a peak at m/z = 263.1, exactly matching the calculated value for the molecular weight of protonated triphenylphosphine (C₁₈H₁₅P–H⁺, m/z = 263.9).[10] Moreover, in the absence of NaN₃, a peak at m/z = 483.1 is observed, which exactly matches the calculated value for the molecular weight of the olefinic triphenylphosphonium ion II (C₃₀H₂₈O₂SP⁺, m/z = 483.1) (vide infra, Scheme [4]).[10] In the ³¹P NMR spectra for the by-product, a strong signal at –5.41 ppm should also be assigned to triphenylphosphine.[10] Triphenylphosphine oxide, however, is a well-known by-product of the Wittig reaction.[11] In addition, the possibility of the addition of azides to electron-deficient olefins like 4a was examined by coupling ethyl cinnamate (4a) with sodium azide under similar conditions. A negative result was observed (Scheme [5]), which indicates that 4a is not an intermediate for triazole product but a by-product (Table [1]). Accordingly, a plausible pathway for the formation of Ph₃P and the triazole product is described in Scheme [4]. In the presence of l-proline and sodium azide, phosphonium salt I couples with protonated aldehyde to form the olefinic phosphorus salt II.[12] [13] A [3+2] cycloaddition between II and the azide anion generates the 4,5-disubstituted triazole product,[14] and triphenylphosphine[15] is released via the aromatization-promoted elimination.

Scheme 4 Proposed mechanism for sequentially coupling phosphonium salt with aldehyde and sodium azide

Scheme 5 No Reaction between 4a and sodium azide

In conclusion, a multi-component reaction to construct 4,5-disubstituted 1H-1,2,3-triazoles by sequentially coupling phosphonium salts with aldehydes and azide has been developed. This method features mild and metal-free conditions. Starting from commercial and readily available reagents, it provides an easy access to diversely functionalized 4,5-disubstituted 1H-1,2,3-triazoles. Notably, the olefinic triphenylphosphonium salt was previously demonstrated to be generated via the coupling of phosphonium salts with aldehydes.

All reactions were performed under air. All reagents were used without further purification. Column chromatography was used for isolating the product and performed using 200–300 mesh silica gel with the proper solvent system according to TLC analysis using KMnO₄ stain and UV light to visualize the reaction components. NMR spectra were recorded in CDCl₃, CD₃OD or DMSO-d ₆, with proton and carbon resonances at 300 or 400 and 75 MHz, respectively, and are referenced to the residual solvent signal at δ = 7.28 (CDCl₃), 4.89 (CD₃OD), 2.50 ppm (DMSO-d ₆) for ¹H and δ = 77.27 (CDCl₃), 47.82 (CD₃OD), 40.17 ppm (DMSO-d ₆) for ¹³C. Data for ¹H are reported as follows: chemical shift (δ ppm), multiplicity (standard abbreviations), coupling constant, and integration. Data for ¹³C NMR are reported in terms of chemical shift. MS and HRMS were measured in ESI mode, and the mass analysis mode of the HRMS was TOF.

4,5-Disubstituted 1,2,3-Triazoles; Ethyl 4-Phenyl-1H-1,2,3-triazole-5-carboxylate (3a);[16]

Typical Procedure

To a reaction flask equipped with a magnetic stir bar was added (ethoxycarbonylmethyl)triphenylphosphonium bromide (1a; 345 mg, 0.8 mmol), benzaldehyde (2a; 128 mg, 1.2 mmol), NaN₃ (79 mg, 1.2 mmol), and l-proline (9 mg, 0.08 mmol). The mixture was dissolved in DMSO (5 mL) and stirred at r.t. for 24 h. After completion of the reaction, the mixture was poured into ice-water and extracted with EtOAc (4 × 20 mL). The combined organic layers were dried (Na₂SO₄), and the solvent was concentrated in vacuo. The residue was isolated by chromatography on silica gel with EtOAc/PE (1:2) as eluent to afford the product 3a; yield: 131 mg (75%); white solid; mp 92–94 °C; R_f = 0.55 (PE/EtOAc 1:1).

¹H NMR (300 MHz, CDCl₃): δ = 7.87–7.85 (m, 2 H_arom), 7.48–7.47 (m, 3 H_arom), 4.45 (q, J = 7.1 Hz, 2 H, OCH ₂CH₃), 1.38 (t, 3 H, J = 7.1 Hz, OCH₂CH ₃).

¹³C NMR (75 MHz, CDCl₃): δ = 161.1, 146.2, 134.1, 129.7, 129.3, 128.3, 127.7, 61.7, 14.1.

HRMS (ESI): m/z calcd for C₁₁H₁₂N₃O₂ [M + H]⁺: 218.0924; found: 218.0916.

Ethyl 4-(p-Tolyl)-1H-1,2,3-triazole-5-carboxylate (3b)[5d]

Eluent: EtOAc/PE (1:2); yield: 185 mg (79%); white solid; mp 129–130 °C; R_f = 0.55 (PE/EtOAc 1:1).

¹H NMR (300 MHz, CDCl₃): δ = 7.73 (d, J = 8.1 Hz, 2 H_arom), 7.16 (d, J = 8.1 Hz, 2 H_arom), 4.40 (q, J = 7.1 Hz, 2 H, OCH ₂CH₃), 2.40 (s, 3 H, ArCH ₃), 1.33 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, CDCl₃): δ = 161.3, 146.2, 140.1, 134.1, 129.3, 129.3, 124.8, 61.9, 21.6, 14.3.

HRMS (ESI): m/z calcd for C₁₂H₁₄N₃O₂ [M + H]⁺: 232.1081; found: 232.1074.

Ethyl 4-(4-Methoxyphenyl)-1H-1,2,3-triazole-5-carboxylate (3c)[17]

Eluent: EtOAc/PE (1:2); yield: 133 mg (78%); white solid; mp 122–125 °C; R_f = 0.54 (PE/EtOAc 1:1).

¹H NMR (300 MHz, CDCl₃): δ = 7.77 (d, J = 8.8 Hz, 2 H_arom), 6.92 (d, J = 8.9 Hz, 2 H_arom), 4.36 (q, J = 7.1 Hz, 2 H, OCH ₂CH₃), 3.82 (s, 3 H, OCH₃), 1.30 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, CDCl₃): δ = 161.6, 160.88, 145.3, 133.7, 130.9, 119.7, 113.9, 61.7, 55.5, 14.3.

HRMS (ESI): m/z calcd for C₁₂H₁₄N₃O₃ [M + H]⁺: 248.1030; found: 248.1027.

Ethyl 4-(2-Methoxyphenyl)-1H-1,2,3-triazole-5-carboxylate (3d)[17]

Eluent: EtOAc/PE (1:2); yield: 129 mg (75%); white solid; mp 123–125 °C; R_f = 0.53 (PE/EtOAc 1:1).

¹H NMR (300 MHz, CD₃OD): δ = 7.62–7.28 (m, 2 H_arom), 7.28–6.82 (m, 2 H_arom), 4.23 (q, J = 7.1 Hz, 2 H, OCH ₂CH₃), 3.77 (s, 3 H, OCH₃), 1.18 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, CD₃OD): δ = 161.6, 157.3, 139.9, 135.7, 131.4, 131.0, 120.2, 116.3, 110.9, 60.9, 54.9, 13.2.

HRMS (ESI): m/z calcd for C₁₂H₁₄N₃O₃ [M + H]⁺: 248.1030; found: 248.1026.

Ethyl 4-(4-Bromophenyl)-1H-1,2,3-triazole-5-carboxylate (3e)[5d]

Eluent: EtOAc/PE (1:2); yield: 169 mg (80%); white solid; mp 169–171 °C; R_f = 0.56 (PE/EtOAc 1:1).

¹H NMR (300 MHz, DMSO-d ₆): δ = 7.74 (d, J = 8.5 Hz, 2 H_arom), 7.68 (d, J = 8.6 Hz, 2 H_arom), 4.28 (q, J = 7.1 Hz, 2 H, OCH ₂CH₃), 1.25 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, DMSO-d ₆): δ = 161.4, 145.1, 131.9, 131.8, 131.5, 128.4, 123.4, 61.5, 14.6.

HRMS (ESI): m/z calcd for C₁₁H₁₁BrN₃O₂ [M + H]⁺: 296.0029, 298.0009; found: 296.0029, 298.0006.

Ethyl 4-(4-Fluorophenyl)-1H-1,2,3-triazole-5-carboxylate (3f)[5e]

Eluent: EtOAc/PE (1:2); yield: 126 mg (65%); colorless oil; R_f = 0.55 (PE/EtOAc 1:1).

¹H NMR (300 MHz, CDCl₃): δ = 7.91 (dd, J ₁ = 5.6 Hz, J ₂ = 8.4 Hz, 2 H_arom), 7.15–7.2 (m, 2 H_arom H), 4.45 (q, J = 7.2 Hz, 2 H, OCH ₂CH₃), 1.40 (t, J = 7.2 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, CDCl₃): δ = 165.4 (d, J = 248 Hz), 161.2, 146.8, 134.2, 131.6 (d, J = 7.4 Hz), 124.5, 115.8 (d, J = 22.6 Hz), 62.2, 14.4.

HRMS (ESI): m/z calcd for C₁₁H₁₁FN₃O₂ [M + H]⁺: 236.0830; found: 236.0826.

Ethyl 4-(3-Chlorophenyl)-1H-1,2,3-triazole-5-carboxylate (3g)[5e]

Eluent: EtOAc/PE (1:2); yield: 153 mg (63%); white solid; mp 101–103 °C; R_f = 0.56 (PE/EtOAc 1:1).

¹H NMR (400 MHz, CD₃OD): δ = 7.90 (s, 1 H_arom), 7.81–7.70 (m, 1 H_arom), 7.54–7.42 (m, 2 H_arom), 4.39 (q, J = 7.1 Hz, 2 H, OCH ₂CH₃), 1.36 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, CD₃OD): δ = 160.8, 144.7, 133.9, 130.6, 129.7, 129.2, 129.1, 127.6, 127.5, 61.3, 13.2.

HRMS (ESI): m/z calcd for C₁₁H₁₁ClN₃O₂ [M + H]⁺: 252.0534; found: 252.0524.

Ethyl 4-[4-(Methylthio)phenyl]-1H-1,2,3-triazole-5-carboxylate (3h)

Eluent: EtOAc/PE (1:2); yield: 152 mg (81%); white solid; mp 118–120 °C; R_f = 0.51 (PE/EtOAc 1:1).

¹H NMR (300 MHz, CDCl₃): δ = 7.78 (d, J = 8.4 Hz, 2 H_arom), 7.29 (d, J = 8.4 Hz, 2 H_arom), 4.40 (q, J = 7.1 Hz, 2 H, OCH ₂CH₃), 2.51 (s, 3 H, SCH₃), 1.33 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, CDCl₃): δ = 161.3, 141.3, 129.7, 129.7, 125.8, 124.3, 124.1, 62.0, 15.5, 14.3.

HRMS (ESI): m/z calcd for C₁₂H₁₄N₃O₂S [M + H]⁺: 264.0801; found: 264.0793.

Ethyl 4-[4-(Dimethylamino)phenyl]-1H-1,2,3-triazole-5-carboxylate (3i)[18]

Eluent: EtOAc/PE (2:3), yield: 183 mg (65%); white solid; mp 124–126 °C; R_f = 0.43 (PE/EtOAc 1:1).

¹H NMR (400 MHz, CD₃OD): δ = 7.68 (d, J = 8.9 Hz, 2 H_arom), 6.83 (d, J = 8.9 Hz, 2 H_arom), 4.38 (q, J = 7.1 Hz, 2 H, OCH ₂CH₃), 3.04 [s, 6 H, N(CH₃)₂], 1.37 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, CD₃OD): δ = 161.6, 151.8, 143.8, 130.0, 128.7, 113.7, 111.5, 60.9, 39.2, 13.3.

HRMS (ESI): m/z calcd for C₁₃H₁₆N₄O₂ [M + H]⁺: 261.1346; found: 261.1344.

Ethyl 4-[4-(Trifluoromethyl)phenyl]-1H-1,2,3-triazole-5-carboxylate (3j)[17]

Eluent: EtOAc/PE (1:2); yield: 147 mg (78%); white solid; mp 151–152 °C; R_f = 0.51 (PE/EtOAc 1:1).

¹H NMR (400 MHz, CD₃OD): δ = 8.04 (d, J = 8.2 Hz, 2 H_arom), 7.79 (d, J = 8.2 Hz, 2 H_arom), 4.39 (q, J = 7.1 Hz, 2H, OCH ₂CH₃), 1.35 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, CD₃OD): δ = 160.8, 145.1, 132.9, 130.7, 129.8, 126.1, 124.9 (q, J = 204 Hz), 122.5, 61.4, 13.2.

HRMS (ESI): m/z calcd for C₁₂H₁₁F₃N₃O₂ [M + H]⁺: 286.0798; found: 286.0788.

Ethyl 4-(4-Hydroxyphenyl)-1H-1,2,3-triazole-5-carboxylate (3k)[17]

Eluent: EtOAc/PE (1:1); yield: 106 mg (28%); white solid; mp 164–166 °C; R_f = 0.40 (PE/EtOAc 1:1).

¹H NMR (400 MHz, CD₃OD): δ = 7.64 (d, J = 8.7 Hz, 2 H_arom), 6.90 (d, J = 8.7 Hz, 2 H_arom), 4.36 (q, J = 7.1 Hz, 2 H, OCH ₂CH₃), 1.35 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, CD₃OD): δ = 161.4, 159.1, 144.0, 130.7, 125.5, 118.0, 115.0, 61.0, 13.3.

HRMS (ESI): m/z calcd for C₁₁H₁₂N₃O₃ [M + H]⁺: 234.0873; found: 234.0867.

Ethyl 4-[4-(Methoxycarbonyl)phenyl]-1H-1,2,3-triazole-5-carboxylate (3l)[17]

Eluent: EtOAc/PE (1:2); yield: 107 mg (45%); white solid; mp 108–110 °C; R_f = 0.50 (PE/EtOAc 1:1).

¹H NMR (400 MHz, CD₃OD): δ = 8.12 (d, J = 8.5 Hz, 2 H_arom), 7.95 (d, J = 8.5 Hz, 2 H_arom), 4.39 (d, J = 7.1 Hz, 2 H, OCH ₂CH₃), 3.96 (s, 3 H, OCH₃), 1.35 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, CD₃OD): δ = 166.7, 160.9, 145.1, 133.3, 130.6, 129.2, 129.1, 126.4, 61.4, 51.6, 13.3.

HRMS (ESI): m/z calcd for C₁₃H₁₄N₃O₄ [M + H]⁺: 276.0979; found: 276.0969.

Ethyl 4-(4-Cyanophenyl)-1H-1,2,3-triazole-5-carboxylate (3m)[17]

Eluent: EtOAc/PE (1:1), yield: 135 mg (38%); white solid; mp 119–122 °C; R_f = 0.47 (PE/EtOAc 1:1).

¹H NMR (301 MHz, CD₃OD): δ = 8.01 (d, J = 8.4 Hz, 2 H_arom), 7.79 (d, J = 8.4 Hz, 2 H_arom), 4.34 (q, J = 7.1 Hz, 2 H, OCH ₂CH₃), 1.31 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, CD₃OD): δ = 160.6, 145.2, 133.8, 132.2, 131.9, 130.0, 118.2, 112.6, 61.5, 13.2.

HRMS (ESI): m/z calcd for C₁₂H₁₁N₄O₂ [M + H]⁺: 243.0877; found: 243.0866.

Ethyl 4-(4-Nitrophenyl)-1H-1,2,3-triazole-5-carboxylate (3n)[18]

Eluent: EtOAc/PE (1:1); yield: 157 mg (31%); white solid; mp 178–180 °C; R_f = 0.45 (PE/EtOAc 1:1).

¹H NMR (300 MHz, CD₃OD): δ = 8.29 (d, J = 9.0 Hz, 2 H_arom), 8.10 (d, J = 9.0 Hz, 2 H_arom), 4.37 (q, J = 7.1 Hz, 2 H, OCH ₂CH₃), 1.34 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, CD₃OD): δ = 160.6, 148.3, 145.1, 145.1, 135.6, 130.2, 123.1, 61.6, 13.2.

HRMS (ESI): m/z calcd for C₁₁H₁₁N₄O₄ [M + H]⁺: 263.0775; found: 263.0768.

Ethyl 4-(Pyridin-3-yl)-1H-1,2,3-triazole-5-carboxylate (3o)[19]

Eluent: EtOAc/PE (1:1); yield: 171 mg (35%); white solid; mp 158–160 °C; R_f = 0.48 (PE/EtOAc 1:1).

¹H NMR (300 MHz, CD₃OD): δ = 9.61 (s, 1 H_pyridyl), 9.33 (d, J = 4.8 Hz, 1 H_pyridyl), 8.86 (d, J = 7.8 Hz, 1 H_pyridyl), 8.22–8.18 (m, 1 H_pyridyl), 4.97 (q, J = 7.1 Hz, 2 H, OCH ₂CH₃), 1.92 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, CD₃OD): δ = 161.2, 151.0, 150.7, 150.1, 137.3, 137.0, 125.6, 123.9, 61.6, 14.6.

HRMS (ESI): m/z calcd for C₁₀H₁₁N₄O₂ [M + H]⁺: 219.0877; found: 219.0870.

Ethyl 4-(Thiophen-2-yl)-1H-1,2,3-triazole-5-carboxylate (3p)[5h]

Eluent: EtOAc/PE (1:2); yield: 118 mg (63%); white solid; mp 144–146 °C; R_f = 0.50 (PE/EtOAc 1:1).

¹H NMR (400 MHz, CD₃OD): δ = 7.97 (d, J = 3.8 Hz, 1 H_thiophenyl), 7.56 (d, J = 4.9 Hz, 1 H_thiophenyl), 7.14 (dd, J = 4.9, 3.8 Hz, 1 H_thiophenyl), 4.42 (q, J = 7.1 Hz, 2 H, OCH ₂CH₃), 1.40 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃).

¹³C NMR (75 MHz, CD₃OD): δ = 160.8, 138.6, 136.3, 130.5, 129.5, 127.9, 127.3, 61.4, 13.3.

HRMS (ESI): m/z calcd for C₉H₁₀N₃O₂S [M + H]⁺: 224.0488; found: 224.0482.

Ethyl 4-Propyl-1H-1,2,3-triazole-5-carboxylate (3q)[20]

Eluent: EtOAc/PE (1:1); yield: 104 mg (71%); white solid; mp 93–95 °C; R_f = 0.46 (PE/EtOAc 1:1).

¹H NMR (300 MHz, CDCl₃): δ = 4.41 (q, J = 7.1 Hz, 2 H, OCH ₂CH₃), 3.04 (t, J = 7.5 Hz, 2 H, CH ₂CH₂CH₃), 1.79-1.67 (m, 2 H CH₂CH ₂CH₃), 1.35 (t, J = 7.1 Hz, 3 H, OCH₂CH ₃), 0.94 (t, J = 7.4 Hz, 3 H, CH₂CH₂CH ₃).

¹³C NMR (75 MHz, CDCl₃): δ = 161.9, 146.3, 135.2, 61.4, 26.2, 22.4, 14.4, 13.9.

HRMS (ESI): m/z calcd for C₈H₁₄N₃O₂ [M + H]⁺: 184.1081; found: 184.1077.

Phenyl(4-phenyl-1H-1,2,3-triazol-5-yl)methanone (5a)[21]

Eluent: EtOAc/PE (1:3); yield: 162 mg (43%); white solid; mp 117–120 °C; R_f = 0.62 (PE/EtOAc 1:1).

¹H NMR (300 MHz, CDCl₃): δ = 8.34–7.97 (m, 2 H_arom), 7.97–6.94 (m, 8 H_arom).

¹³C NMR (75 MHz, CDCl₃): δ = 188.4, 171.6, 146.2, 133.8, 130.8, 130.4, 130.0, 129.1, 128.8, 128.7, 128.6.

HRMS (ESI): m/z calcd for C₁₅H₁₂N₃O [M + H]⁺: 250.0975; found: 250.0963.

Phenyl[4-(p-tolyl)-1H-1,2,3-triazol-5-yl]methanone (5b)[22]

Eluent: EtOAc/PE (1:3); yield: 149 mg (38%); white solid; mp 138–140 °C; R_f = 0.62 (PE/EtOAc 1:1).

¹H NMR (300 MHz, DMSO-d ₆): δ = 8.11 (d, J = 7.6 Hz, 2 H_arom), 7.67–7.59 (m, 3 H_arom), 7.48 (t, J = 7.6 Hz, 2 H_arom), 7.22 (d, J = 7.9 Hz, 2 H_arom), 2.39 (s, 3 H, ArCH ₃).

¹³C NMR (75 MHz, DMSO-d ₆): δ = 188.5, 145.1, 141.3, 139.7, 137.9, 133.9, 130.8, 129.7, 129.2, 129.1, 125.9.

HRMS (ESI): m/z calcd for C₁₆H₁₄N₃O [M + H]⁺: 264.1131; found: 264.1130.

Cyclopropyl(4-phenyl-1H-1,2,3-triazol-5-yl)methanone (5c)

Eluent: EtOAc/PE (1:2). Yield: 120 mg (56%); white solid; mp 113–116 °C; R_f = 0.59 (PE/EtOAc 1:1).

¹H NMR (300 MHz, CDCl₃): δ = 7.82–7.54 (m, 2 H_arom), 7.54–7.19 (m, 3 H_arom), 3.08–3.01 (m, 1 H, CH), 1.24–1.23 (m, 2 H, CH₂), 1.05–1.01(m, 2 H, CH₂).

¹³C NMR (75 MHz, CDCl₃): δ = 195.9, 144.1, 141.8, 133.9, 130.4, 130.1, 129.4, 128.6, 127.5, 29.9, 19.5, 12.9.

HRMS (ESI): m/z calcd for C₁₂H₁₂N₃O [M + H]⁺: 214.0975; found: 214.0968.

4-(4-Fluorophenyl)-1H-1,2,3-triazole-5-carbonitrile (5d)[23]

Eluent: EtOAc/PE (1:1); yield: 163 mg (56%); white solid; mp 190–192 °C; R_f = 0.37 (PE/EtOAc 1:1).

¹H NMR (300 MHz, CD₃OD): δ = 7.97 (dd, J ₁ = 6.8 Hz, J ₂ = 11.6 Hz, 2 H_arom), 7.41–7.15 (m, 2 H_arom).

¹³C NMR (75 MHz, CD₃OD): δ = 165.7 (d, J = 247.6 Hz), 147.1, 129.1 (d, J = 8.6 Hz), 123.4, 116.9, 116.3 (d, J = 22.2 Hz), 112.7.

HRMS (ESI): m/z calcd for C₉H₆FN₄ [M + H]⁺: 189.0571; found: 189.0565.

Spectral data match with those previously reported in the literature.[14]

4-(p-Tolyl)-1H-1,2,3-triazole-5-carbonitrile (5e)[23]

Eluent: EtOAc/PE (1:1); yield: 133 mg (67%); white solid; mp 173–175 °C; R_f = 0.38 (PE/EtOAc 1:1).

¹H NMR (400 MHz, CD₃OD): δ = 7.81 (d, J = 8.2 Hz, 2 H_arom), 7.38 (d, J = 8.0 Hz, 2 H_arom), 2.43 (s, 3 H, ArCH ₃).

¹³C NMR (75 MHz, CD₃OD): δ = 147.0, 141.0, 130.0, 126.5, 123.3, 116.5, 112.9, 20.2.

HRMS (ESI): m/z calcd for C₁₀H₉N₄ [M + H]⁺: 185.0822; found: 185.0813.

4-(4-Methoxyphenyl)-1H-1,2,3-triazole-5-carbonitrile (5f)[23]

Eluent: EtOAc/PE (1:1); yield: 166 mg (61%); white solid; mp 197–200 °C; R_f = 0.33 (PE/EtOAc 1:1).

¹H NMR (300 MHz, CD₃OD): δ = 7.85 (d, J = 8.8 Hz, 2 H_arom), 7.09 (d, J = 8.9 Hz, 2 H_arom), 3.86 (s, 3 H, OCH₃).

¹³C NMR (75 MHz, CD₃OD): δ = 161.8, 128.2, 118.3, 116,1, 114.6, 113.0, 89.8, 54.8.

HRMS (ESI): m/z calcd for C₁₀H₉N₄O [M + H]⁺: 201.0771; found: 201.0775.

• References

• 1a Meldal M. Tornøe CW. Chem. Rev. 2008; 108: 2952
• 1b Wacharasindhu S. Bardhan S. Wan ZK. Tabei K. Mansour TS. J. Am. Chem. Soc. 2009; 131: 4174
• 1c Liu Y. Yan W. Chen Y. Petersen JL. Shi X. Org. Lett. 2008; 10: 5385
• 1d Katritzky AR. Bobrov S. Kirichenko K. Ji Y. Steel PJ. J. Org. Chem. 2003; 68: 5713
• 1e Reid AK. McHugh CJ. Richie G. Graham D. Tetrahedron Lett. 2006; 47: 4201
• 1f Verma AK. Singh J. Chaudhary R. Tetrahedron Lett. 2007; 48: 7199
• 1g Dai Q. Gao W. Liu D. Kapzes LM. Zhang X. J. Org. Chem. 2006; 71: 3928
• 1h Jin T. Kamijo S. Yamamoto Y. J. Org. Chem. 2004; 69: 3789
• 2a Kolb HC. Sharpless KB. Drug Discov. Today 2003; 8: 1128
• 2b Manetsch R. Krasiski A. Radi Z. Raushel J. Taylor P. Sharpless KB. Kolb HC. J. Am. Chem. Soc. 2004; 126: 12809
• 2c Whiting M. Muldoon J. Lin YC. Silverman SM. Lindstrom W. Olson AJ. Kolb HC. Finn MG. Sharpless KB. Elder JH. Fokin VV. Angew. Chem. Int. Ed. 2006; 45: 1435
• 2d Wang J. Sui G. Mocharla VP. Lin RJ. Phelps ME. Kolb HC. Tseng HR. Angew. Chem. Int. Ed. 2006; 45: 5276
• 2e Sugawara A. Sunazuka T. Hirose T. Nagai K. Yamaguchi Y. Hanaki H. Sharpless KB. Omura S. Bioorg. Med. Chem. Lett. 2007; 17: 6340
• 2f Chen H. Taylor JL. Abrams SR. Bioorg. Med. Chem. Lett. 2007; 17: 1979
• 2g Moorhouse AD. Moses JE. ChemMedChem 2008; 3: 715
• 2h Tron GC. Pirali T. Billington RA. Canonico PL. Sorba G. Genazzani AA. Med. Res. Rev. 2008; 28: 278
• 3a Wu P. Feldman AK. Nugent AK. Hawker CJ. Scheel A. Voit B. Pyun J. Fre’chet JM. J. Sharpless KB. Fokin VV. Angew. Chem. Int. Ed. 2004; 43: 3928
• 3b Aucagne V. Ha’nni KD. Leigh DA. Lusby PJ. Walker DB. J. Am. Chem. Soc. 2006; 128: 2186
• 3c Ye CF. Gard GL. Winter RW. Syvret RG. Twamley B. Shreeve JM. Org. Lett. 2007; 9: 3841
• 3d Liu QC. Zhao P. Chen YM. J. Polym. Sci., Part A: Polym. Chem. 2007; 45: 3330
• 3e Nandivada H. Jiang XW. Lahann J. Adv. Mater. 2007; 19: 2197
• 3f Angelos S. Yang YW. Patel K. Stoddart JF. Zink JI. Angew. Chem. Int. Ed. 2008; 45: 1435

Selected examples of methods for synthesizing 1,2,3-triazoles:
• 4a Journet M. Cai D. Kowal JJ. Larsen RD. Tetrahedron Lett. 2001; 42: 9117
• 4b Coats SJ. Link JS. Gauthier D. Hlasta D. Org. Lett. 2005; 7: 1469
• 4c Gracias V. Darczak D. Gasiecki AF. Djuric SW. Tetrahedron Lett. 2005; 46: 9053
• 4d Majireck M. Weinreb SM. J. Org. Chem. 2006; 71: 8680
• 4e Aucagne V. Leigh DA. Org. Lett. 2006; 8: 4505
• 4f Boren BC. Narayan S. Rasmussen LK. Zhang L. Zhao H. Lin Z. Jia G. Fokin V. J. Am. Chem. Soc. 2008; 130: 8923
• 5a Journet M. Cai D. Kowal JJ. Tetrahedron Lett. 2001; 42: 9117
• 5b Zefirov NS. Chapovskaya NK. Kolesnikov VV. J. Chem. Soc., Chem. Commun. 1971; 1001
• 5c Quiclet-Sire B. Zard SZ. Synthesis 2005; 3319
• 5d Wang T. Hu XC. Huang XJ. J. Braz. Chem. Soc. 2012; 23: 1119
• 5e Hu Q. Liu Y. Deng X. Adv. Synth. Catal. 2016; 358: 1689
• 5f Gao Y. Lam Y. Org. Lett. 2006; 8: 3283
• 5g Augustine JK. Boodappa C. Venkatachaliah S. Org. Biomol. Chem. 2014; 12: 2280
• 5h Chai H. Guo R. Yin W. ACS Comb. Sci. 2015; 17: 147
• 5i Ponpandian T. Muthusubramanian S. Tetrahedron Lett. 2012; 53: 59
• 5j Wu L. Wang X. Chen Y. Synlett 2016; 27: 437
• 5k Thomas J. John J. Parekh N. Dehaen W. Angew. Chem. Int. Ed. 2014; 53: 10155
• 6a Wittig G. Geissler G. Justus Liebigs Ann. Chem. 1953; 580: 44
• 6b Maryanoff BE. Reitz AB. Chem. Rev. 1989; 89: 863
• 6c Cattelan L. Noe M. Selva M. Demitri N. Perosa A. ChemSusChem 2015; 8: 3963
• 6d Lémaire S. Houpis I. Wechselberger R. Langens J. Vermeulen WA. A. Smets N. Nettekoven U. Wang Y. Xiao T. Qu H. Liu R. Jonckers TH. M. Raboisson P. Vandyck K. Nilsson KM. Farina V. J. Org. Chem. 2011; 76: 297
• 6e Spallarossa M. Wang Q. Riva R. Zhu J. Org. Lett. 2016; 18: 1622
• 6f Mysĺiwiec D. Lis T. Gregoliński J. Stępień M. J. Org. Chem. 2015; 80: 6300
• 6g Xia X. Toy PH. Synlett 2015; 26: 1737
• 6h Cachatra V. Almeida A. Sardinha J. Lucas SD. Gomes A. Vaz PD. Florêncio MH. Nunes R. Vila-Viçosa D. Calhorda MJ. Rauter AP. Org. Lett. 2015; 17: 5622
• 6i Sengupta S. Duan H. Lu W. Petersen JL. Shi X. Org. Lett. 2008; 10: 1493
• 6j Schirmer ML. Adomeit S. Werner T. Org. Lett. 2015; 17: 3078
• 7 Wu G.-L. Wu Q.-P. Adv. Synth. Catal. 2018; 360: in press, DOI: 10.1002/adsc.201701587
• 8a Taber DF. Sheth RB. J. Org. Chem. 2008; 73: 8030
• 8b Leung PS. W. Teng Y. Toy PH. Org. Lett. 2010; 12: 4996
• 9a El-Batta A. Jiang C. Zhao W. Anness R. Cooksy AL. Bergdahl M. J. Org. Chem. 2007; 72: 5244
• 9b Bazhenov DN. Pevzner MS. Ostrovsh Gindin VA. Shcherbinin NB. Zhniaev VN. Zh. Org. Khim. 1994; 30: 791
• 9c Hudson RF. Chopard PA. J. Org. Chem. 1963; 28: 2446
• 10 The LCMS data for monitoring the reaction of synthesizing compound 3h and the ³¹P NMR spectrum of the triphenylphosine by-product are provided in the Supporting Information.
• 11a Li AH. Dai LX. Chem. Rev. 1997; 97: 2341
• 11b Xie P. Huang Y. Org. Biomol. Chem. 2015; 13: 8578
• 12a Northtrup AB. MacMillan DW. C. J. Am. Chem. Soc. 2002; 124: 6798
• 12b Storer RI. MacMillan DW. C. Tetrahedron 2004; 60: 7705
• 13a Byrne PA. Gilheany DG. Chem. Soc. Rev. 2013; 42: 6670
• 13b Sugiura M. Ashikari Y. Nakaijima M. J. Org. Chem. 2015; 80: 8830
• 14a Augustine JK. Boodappa C. Venkatachaliah S. Org. Biomol. Chem. 2014; 12: 2280
• 14b Ye LW. Han X. Sun XL. Tang Y. Tetrahedron 2008; 64: 1487
• 15a Du Y. Lu X. Zhang C. Angew. Chem. Int. Ed. 2003; 42: 1035
• 15b Xie P. Huang Y. Org. Biomol. Chem. 2015; 13: 8578
• 15c Zhou R. He Z. Eur. J. Org. Chem. 2016; 11: 1937
• 16 Rolf HP. Pasquale R. Aust. J. Chem. 1994; 47: 1375
• 17 Amantini DF. Piermatti O. Pizzo F. Zunino E. Vaccaro L. J. Org. Chem. 2005; 70: 6526
• 18 Berestovitskaya VM. Baichurin RI. Aboskalova NI. Baichurina LV. Trukhin EV. Fel’gendler AV. Gensirovskaya MA. Russ. J. Gen. Chem. 2016; 86: 1266
• 19 Chen Y. Hu Q. Liu Y. Faming Zhuanli Shenqing 2016; 105541796 . Chem. Abstr. 2016, 164, 602163
• 20 Shin C. Yonezawa Y. Yoshimura J. Tetrahedron Lett. 1974; 15: 7
• 21 Li J. Wang D. Zhang Y. Li J. Chen B. Org. Lett. 2009; 11: 3024
• 22 Zhu Y. Li J. Liu R. Huaxue Shiji 2016; 38: 565 . Chem. Abstr. 2016, 165, 416564
• 23 Cheng Z. Li W. He F. Zhou J. Zhu X. Bioorg. Med. Chem. 2007; 15: 1533